The drugs could produce huge benefits for people with obesity but also present a major cost challenge given the large percentage of the population that is eligible for them, the report said
The rise corresponds with the established effectiveness of GLP-1 RAs, such as semaglutide and liraglutide, for significant weight loss in people with obesity a group representing roughly 93 million potentially eligible U.S
After one year on Retatrutide, her metabolic assessments revealed significantly improved insulin sensitivity and mitochondrial efficiency, directly correlating with her ability to maintain consistent energy, stable weight, and improved performance during periods of both caloric restriction and dietary flexibility
Last reviewed: July 8, 2026 Last updated: July 8, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Everythingconsultation, prescription, support, and medication deliveryis done online, allowing users across the country to begin GLP-1 treatment without disruption
This ensures you can focus entirely on reaching your health goals without the hassle of navigating insurance complexities
